Anacardic Acids from Amphipterygium adstringens Confer Cytoprotection against 5-Fluorouracil and Carboplatin Induced Blood Cell Toxicity While Increasing Antitumoral Activity and Survival in an Animal Model of Breast Cancer
- PMID: 34071241
- PMCID: PMC8198955
- DOI: 10.3390/molecules26113241
Anacardic Acids from Amphipterygium adstringens Confer Cytoprotection against 5-Fluorouracil and Carboplatin Induced Blood Cell Toxicity While Increasing Antitumoral Activity and Survival in an Animal Model of Breast Cancer
Abstract
Amphipterygium adstringens (cuachalalate) contains anacardic acids (AAs) such as 6-pentadecyl salicylic acid (6SA) that show immunomodulatory and antitumor activity with minimal or no secondary adverse effects. By contrast, most chemotherapeutic agents, such as 5-fluorouracil (5-FU) and carboplatin (CbPt), induce myelosuppression and leukopenia. Here, we investigated the myeloprotective and antineoplastic potential of an AA extract or the 6SA as monotherapy or in combination with commonly used chemotherapeutic agents (5-FU and CbPt) to determine the cytoprotective action of 6SA on immune cells. Treatment of Balb/c breast tumor-bearing female mice with an AA mixture or 6SA did not induce the myelosuppression or leukopenia observed with 5-FU and CbPt. The co-administration of AA mixture or isolated 6SA with 5-FU or CbPt reduced the apoptosis of circulating blood cells and bone marrow cells. Treatment of 4T1 breast tumor-bearing mice with the AA mixture or 6SA reduced tumor growth and lung metastasis and increased the survival rate compared with monotherapies. An increased effect was observed in tumor reduction with the combination of 6SA and CbPt. In conclusion, AAs have important myeloprotective and antineoplastic effects, and they can improve the efficiency of chemotherapeutics, thereby protecting the organism against the toxic effects of drugs such as 5-FU and CbPt.
Keywords: Amphiterygium adstringens; anacardic acids; antineoplastic agent; autologous tumor model; myeloprotective.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8198955/bin/molecules-26-03241-g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8198955/bin/molecules-26-03241-g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8198955/bin/molecules-26-03241-g003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8198955/bin/molecules-26-03241-g004.gif)
Similar articles
-
Amphipterygium adstringens (Schltdl.) Schiede ex Standl (Anacardiaceae): An Endemic Plant with Relevant Pharmacological Properties.Plants (Basel). 2022 Jul 2;11(13):1766. doi: 10.3390/plants11131766. Plants (Basel). 2022. PMID: 35807718 Free PMC article. Review.
-
Anacardic 6-pentadecyl salicylic acid induces apoptosis in breast cancer tumor cells, immunostimulation in the host and decreases blood toxic effects of taxol in an animal model.Toxicol Appl Pharmacol. 2021 Jan 1;410:115359. doi: 10.1016/j.taap.2020.115359. Epub 2020 Dec 5. Toxicol Appl Pharmacol. 2021. PMID: 33290779
-
The antineoplastic agent anacardic 6-pentadecyl salicylic acid produces immunomodulation in vivo via the activation of MAPKs.Toxicol Appl Pharmacol. 2019 Aug 1;376:82-92. doi: 10.1016/j.taap.2019.05.017. Epub 2019 May 24. Toxicol Appl Pharmacol. 2019. PMID: 31129177
-
Wound healing activity of the hydroalcoholic extract and the main metabolites of Amphipterygium adstringens (cuachalalate) in a rat excision model.J Ethnopharmacol. 2022 Jul 15;293:115313. doi: 10.1016/j.jep.2022.115313. Epub 2022 Apr 22. J Ethnopharmacol. 2022. PMID: 35461988
-
Potential biological applications of bio-based anacardic acids and their derivatives.Int J Mol Sci. 2015 Apr 16;16(4):8569-90. doi: 10.3390/ijms16048569. Int J Mol Sci. 2015. PMID: 25894225 Free PMC article. Review.
Cited by
-
An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil's Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negative Breast Cancer.Molecules. 2023 Aug 1;28(15):5808. doi: 10.3390/molecules28155808. Molecules. 2023. PMID: 37570783 Free PMC article.
-
Advances in Cytoprotective Drug Discovery.Molecules. 2023 Jun 2;28(11):4510. doi: 10.3390/molecules28114510. Molecules. 2023. PMID: 37298986 Free PMC article.
-
Green Synthesis and Antiproliferative Activity of Gold Nanoparticles of a Controlled Size and Shape Obtained Using Shock Wave Extracts from Amphipterygium adstringens.Bioengineering (Basel). 2023 Mar 30;10(4):437. doi: 10.3390/bioengineering10040437. Bioengineering (Basel). 2023. PMID: 37106624 Free PMC article.
-
Amphipterygium adstringens (Schltdl.) Schiede ex Standl (Anacardiaceae): An Endemic Plant with Relevant Pharmacological Properties.Plants (Basel). 2022 Jul 2;11(13):1766. doi: 10.3390/plants11131766. Plants (Basel). 2022. PMID: 35807718 Free PMC article. Review.
References
-
- Carr C., Ng J., Tim W. The side effects of chemotherapeutic agents. Curr. Anaesth. Crit. CARE. 2008;19:70–79. doi: 10.1016/j.cacc.2008.01.004. - DOI
-
- Kim H.S., Kim H.G., Im H.J., Lee J.S., Lee S.B., Kim W.Y., Lee H.W., Lee S.K., Byun C.K., Son C.G. Antiemetic and Myeloprotective Effects of Rhus verniciflua Stoke in a Cisplatin-Induced Rat Model. Evidence-based Complement. Altern. Med. 2017;2017:9830342. doi: 10.1155/2017/9830342. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources